Am. J. Respir. Crit. Care Med., Volume 159, Number 2, February 1999, 571-579

Response to Inhaled Nitric Oxide in Patients with Acute Right Heart Syndrome

SANGEETA BHORADE, JEFFREY CHRISTENSON, MICHAEL O'CONNOR, ANNICK LAVOIE, ANNE POHLMAN, and JESSE B. HALL

Departments of Medicine and Anesthesia and Critical Care, University of Chicago, Chicago, Illinois

Inhaled nitric oxide (iNO), a selective pulmonary vasodilator, has been shown to decrease pulmonary artery pressures but not increase cardiac output in hemodynamically stable patients with a variety of causes of pulmonary hypertension. The response to iNO in hemodynamically unstable patients with acute right heart syndrome has not been previously described. We determined the response to iNO in 26 critically ill adult patients with acute right heart failure defined by echocardiographic criteria. Patients received iNO through the inspiratory limb of the ventilator in increments of 10 ppm with hemodynamic and gas-exchange measurements made before and after each level. When maximal effect was seen, iNO was discontinued to compare parameters with baseline. iNO significantly increased cardiac output (5.5 ± 3 to 6.4 ± 4 L/min), stroke volume (54 ± 27 to 65 ± 38 ml), and mixed-venous oxygen saturation (69 ± 8 to 73 ± 10%), all p < 0.01. With discontinuation of iNO, all parameters returned immediately to baseline. These parameters of improved perfusion were related to a decrease in pulmonary vascular pressures and resistance. In a subset of approximately 50% of patients, these changes were substantial (> 20%) and in approximately 25% of all patients, the improvement in hemodynamic measures permitted a decrease in other vasoactive drug administration. The mean concentration of iNO required to achieve these effects was 35 ppm, and 85% of patients exhibiting a substantial improvement in hemodynamics did so at a concentration of iNO of less than or equal to 40 ppm. Underlying causes of right heart failure and baseline hemodynamics did not predict response to iNO, but the use of -agonist catecholamines did. We conclude iNO improves hemodynamics in patients with respiratory failure, shock, and right ventricular dysfunction. Although mortality was not a key end point in this pilot study, it was high for both responders and nonresponders to this therapy. Further evaluation of the role of iNO in this patient population is supported by these data.

This article has been cited by other articles:

				K. Subramaniam and J.-P. Yared Management of Pulmonary Hypertension in the Operating Room Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 119 - 136. [Abstract] [PDF]

				S. Takaoka, J. L. Faul, and R. Doyle Current Therapies for Pulmonary Arterial Hypertension Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2007; 11(2): 137 - 148. [Abstract] [PDF]

				I. George, S. Xydas, V. K. Topkara, C. Ferdinando, E. C. Barnwell, L. Gableman, R. N. Sladen, Y. Naka, and M. C. Oz Clinical Indication for Use and Outcomes After Inhaled Nitric Oxide Therapy Ann. Thorac. Surg., December 1, 2006; 82(6): 2161 - 2169. [Abstract] [Full Text] [PDF]

				G. Piazza and S. Z. Goldhaber The Acutely Decompensated Right Ventricle: Pathways for Diagnosis and Management Chest, September 1, 2005; 128(3): 1836 - 1852. [Abstract] [Full Text] [PDF]

				T. S. Maxey, C. D. Smith, J. A. Kern, C. G. Tribble, D. R. Jones, I. L. Kron, and I. K. Crosby Beneficial effects of inhaled nitric oxide in adult cardiac surgical patients Ann. Thorac. Surg., February 1, 2002; 73(2): 529 - 533. [Abstract] [Full Text] [PDF]

				T. W HIGENBOTTAM, M. ASIF, K. MCCORMACK, T. E SIDDONS, E. A G DEMONCHEAUX, K. ASHUTOSH, and K. PHADKE Use of nitric oxide inhalation in COPD Thorax, November 1, 2000; 55(11): 978 - 978. [Full Text]

				R. King, M. Esmail, S. Mahon, J. Dingley, and S. Dwyer Use of nitric oxide for decompensated right ventricular failure and circulatory shock after cardiac arrest Br. J. Anaesth., October 1, 2000; 85(4): 628 - 631. [Abstract] [Full Text] [PDF]

				K. Ashutosh, K. Phadke, J. F. Jackson, and D. Steele Use of nitric oxide inhalation in chronic obstructive pulmonary disease Thorax, February 1, 2000; 55(2): 109 - 113. [Abstract] [Full Text]

				E. R. Schmid, C. Burki, M. H. C. Engel, D. Schmidlin, M. Tornic, and B. Seifert Inhaled Nitric Oxide Versus Intravenous Vasodilators in Severe Pulmonary Hypertension After Cardiac Surgery Anesth. Analg., November 1, 1999; 89(5): 1108 - 1108. [Abstract] [Full Text] [PDF]